TrialInternational journal of clinical oncology2018

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Tomoro Hishiki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.